Adverse events and oncotargeted kinase inhibitors /

Saved in:
Bibliographic Details
Main Authors: Tridente, G.
Corporate Authors: Elsevier Science & Technology.
Published: Academic Press,
Publisher Address: Amsterdam :
Publication Dates: [2017]
©2017
Literature type: eBook
Language: English
Subjects:
Online Access: https://www.sciencedirect.com/science/book/9780128094006
http://www.sciencedirect.com/science/book/9780128094006
Carrier Form: 1 online resource (xix, 715 pages)
Bibliography: Includes bibliographical references and index.
ISBN: 9780128094457
0128094451
Index Number: RC271
CLC: R730.54
Contents: Introduction -- Kinases -- Kinase inhibitors -- Adverse events -- Imantinib -- Gefitinib -- Erlotinib -- Sorafenib -- Sunitinib -- Dasatinib -- Lapatinib -- Nilotinib -- Pazopanib -- Vandetanib -- Vemurafenib -- Crizotinib -- Ruxolitinib -- Axitinib -- Bosutinib -- Regorafenib -- Cabozantinib -- Ponatinib -- Dabrafenib -- Trametinib -- Afatinib -- Idelaisib -- Ibrutinib -- Overview -- Conclusion and perspectives.